SCHEMBL25977097

SCHEMBL25977097

CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OC[C@@H]1CC[C@](C#N)(c2ccc3c(N)ncnn23)O1)OCc1ccc(C#N)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24304671 0.92 LPAR1 (0.30) —
SCHEMBL24304607 0.91 — —
SCHEMBL24304963 0.91 KDM4E (0.30) —
SCHEMBL25976917 0.90 — —
SCHEMBL25976724 0.90 — —
SCHEMBL24304428 0.90 — —
SCHEMBL25976702 0.90 — —
SCHEMBL25976660 0.90 GLP1R (0.30) —
SCHEMBL25976898 0.90 GLP1R (0.30) —
SCHEMBL27457849 0.90 GLP1R (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030904-B2 Phospholipid compounds and uses thereof GILEAD SCIENCES, INC. (US) 2024-07-09 — — US disclosed
US-20230250117-A1 PHOSPHOLIPID COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2023-08-10 — — US disclosed
Send feedback